PharmaReports: Oncology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
Showing results 101 - 150 of 224
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Pipeline Insight: Molecular Targeted Cancer Therapies
- Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take hold of market
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Histone deacetylase inhibitors
- Coxibs - Past Problems and Future Potential
- Aurora Kinase inhibitors - The dawn of a new approach to cancer
- Thrombosis in Cancer - Expanding Focus for Anticoagulants
- Innovative Agents in Lung and Colorectal Cancer - Another Step Nearer the Revolution?
- Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug Delivery
- Stakeholder Insight: Lung Cancer - Third-Generation Cytotoxics Set to Dominate the Market
- Commercial Perspectives: Anti-Hormonals - Tamoxifen to be Obsolete by 2010?
- Commercial Perspectives: Cytotoxics - Third-Generation Cytotoxics To Offset Taxol's Generic Woes
- Pipeline Insight: Breast Cancer - Complex Combinations of Old and New?
- Pipeline Insight: Colorectal Cancer - Avastin and Erbitux Pave The Way For Pipeline Targeted Therapi
- Stakeholder Insight: Local and Locally Advanced Prostate Cancer
- Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer
- Stakeholder Insight: Prostate Cancer Treatment and Commercial Issues
- Stakeholder Opinions: Hepatocellular Carcinoma - Growing Market Seeks New Players
- Stakeholder Insight: Prostate Cancer Treatment in the USA
- Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
- Stakeholder Opinions: Brain Metastases - Turning Prolonged Survival on its Head?
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
- Pipeline Insight: Innovative therapies - Targeted therapy, a clinical and commercial revolution?
- The Cancer Market Outlook to 2009
- The Cancer Market Outlook to 2010
- Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Innovations in Cancer: Novel therapeutics, new diagnostics and future R&D strategies
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- Myelodysplastic Syndromes - First approvals spur interest in niche market
- Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
- Multiple Myeloma - Exploring new targets for multiple drug therapy
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs
- Head and Neck Cancer
- How to Conduct Clinical Trials in China
- Prescription Dermatological Drugs: Worldwide Market
- The Cancer Market Outlook to 2012
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- The Pain Market Outlook to 2011
- Cancer Cell Therapy Markets
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development